$100 Mil. Pharmaceutical Media Business in Play

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

Prescription-drug marketer AstraZeneca Pharmaceuticals is in the early stages of planning a media buying consolidation, sources said. The combined account will be worth an estimated $100 million in billings.

The Wilmington, Del.-based client has quietly begun contacting its roster shops about a review and is developing a request for proposals to send to contenders, sources said.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in